N/A N=189 The OPENS Trial: Offering Women PrEP (Aim 1)
Human Immunodeficiency Virus Transmission · Sexually Transmitted Diseases
Primary: PrEP Prescriptions (As Measured by Chart Review) — 1; 0 Participants — p=0.51
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=200 Provision of HIV Self-Test Kit to Emergency Department Patients
HIV Infections
Primary: Number of Participants Who Did HIV Testing — 36; 9 Participants
Phase 4 N=212 Alignment of PrEP Use With HIV Risk in Young Women and Men
Pre-Exposure Prophylaxis · Sexually Transmitted Diseases, Bacterial · HIV Infections
Primary: Visits With PrEP Dispensation to Female Study Participants Reporting Sexual Behaviors or STI Symptoms — 211 Visits
N/A N=250 Prevalence and Predictors of Neurocognitive Impairment Among HIV-infected Patients
HIV Infections · Memory
Primary: The Prevalence of Neurocognitive Deficits Among HIV-positive Patients as Defined by the Global Deficit Score Based on the Neuropsychological Testing Battery and to…
N/A N=216 Crowdsourcing to Reduce HIV Stigma Among Adolescents and Young Adults in Kazakhstan
Stigma, Social · HIV Testing
Primary: Mean Score Change in Total HIV Stigma Scale — 47.48; 47.89; 44.60; 47.32 units on a scale — p=0.083
N/A N=500 Expanding HIV Testing Among Uganda Adults Who Utilize Traditional Healers
HIV/AIDS · Health Behaviors
Primary: Number of TH Clients Who Received HIV Testing — 57; 250 Participants — p=<0.001
N/A N=128 Podcasting HIV Prevention Within African American Communities
HIV Prevention
Primary: Change in Condom Use Self-Efficacy (From Baseline to 1 Month Follow-up) — 4.4 score on a scale — p=<.001
Phase 4 N=30 An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal
HIV-2 Infection
Primary: Death — 0 Participants
Phase 2 N=58 ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
HIV Infections
Primary: Outcome 1: Serial HIV-1 RNA Levels in Breastmilk. — 2.74; 2.03; 1.70; 1.70 Log10 Viral load copies/ml
N/A N=58 Texting to Improve Adherence in HIV+ With Bipolar Disorder
HIV Disease · Bipolar Disorder
Primary: Proportion Adherent to ARV and Psychotropic Medication by Electronic Monitoring System (MEMS) — 90.3; 90.0; 83.9; 90.0 percentage of taken doses — p=0.95
N/A N=224 Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
HIV Infections · Syphilis
Primary: Participants Linked Either to Care (PrEP or ART) — 51; 50 Participants
N/A N=564 HIV/STI Prevention for Drug-Involved Couples
Sexually Transmitted Infections
Primary: Number of Unprotected Acts of Intercourse — 19.7; 12.9; 18.2 # of unprotected sex acts at 12 months
N/A N=98 Pilot Intervention to Empower HIV Clients as Prevention Advocates in Uganda
HIV
Primary: Change in Engagement HIV Prevention Advocacy — 4.1; 3.8; 4.2; 3.5 units on a scale — p=.017
N/A N=298 HIV Prevention Toolkit for HIV-negative Male Couples
HIV
Primary: Formation of a Sexual Agreement at 6 Months — 56; 66; 48; 24 Participants
N/A N=151 Addressing Drug Use Stigma in Human Immunodeficiency Virus (HIV) Care and Treatment Clinics in Tanzania
Drug Use Stigma in HIV Treatment Clinics
Primary: Modified Opening Minds Scale for Health Providers (OMS-HC) — 22.92; 16.82 score on a scale